genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
News
Drug Discovery
Targeted Protein Degradation Represents a Promising Therapeutic Strategy
Stem Cells
Stem Cell Discovery Could Point to New Strategies for Glaucoma Therapy
Coronavirus
NIH Invests $248.7 Million to Ramp up COVID-19 Testing
OMICs
Sickle Cell Disease Complications Triggered by Gut Microbiome
Cancer
Critical Recurring Mutation Identified in Head and Neck Cancers
Insights
All
Trends for 2020
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
August 2020 Vol. 40 No. 8
Fully Automated Luxury Drug Discovery
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Targeted Protein Degradation Represents a Promising Therapeutic Strategy
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Illumina
Illumina
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Illumina
Illumina Bolsters Its Cloud Portfolio with BlueBee Acquisition
Illumina
Notes and Takeaways from JPM 2020
Illumina
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Illumina
Illumina Unveils New Sequencing Systems, Roche Clinical Dx Collaboration
Illumina
Illumina, PacBio Scrap $1.2B Merger, Citing “Continued Uncertainty”
Illumina
Deal or No Deal: FTC Challenge Poses No Threat to Illumina,...
Illumina
Illumina, Lundbeck Foundation GeoGenetics Centre to Study Microbes’ Role in Neuropsychiatric...
Illumina
Illumina CEO Talks $100 Genome, Tariffs, and NovaSeq at J.P. Morgan
Illumina
Illumina’s Acquisition of PacBio: Accelerating the Pace of Genomic Discovery
Illumina
Illumina Adds Long-Read Capabilities with $1.2B PacBio Acquisition
Illumina
PacBio Sells Sequel System Sequencers to Annoroad
Illumina
Illumina’s Push to Democratize Genomics with the iSeq 100
Illumina
Helix, Illumina Partner to Support Startups for DNA-Driven Consumer Products
Illumina
Illumina Donates 8,000+ Associations of Tumor-Linked Variants to CIViC
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
